Stopping smoking before bronchoscopy or CT‑guided lung biopsy
Official title: Smoking Cessation Before Intervention in Patients With Pulmonary Nodules Requiring Further Diagnosis
Run by RWTH Aachen University · NCT07322796 · Data updated 2026-11-12
This project tests whether offering immediate quit-smoking support and measuring nicotine markers helps people who smoke and are having a bronchoscopy or CT‑guided lung biopsy stop smoking.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | RWTH Aachen University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Aachen, North Rhine-Westphalia) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | August 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | January 28, 2026 |
| Trial ID | NCT07322796 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Active smokers who present to the pneumology outpatient clinic for evaluation of a suspicious pulmonary nodule and who are willing to participate in counseling and biochemical testing are ideal candidates.
✕Probably not a fit
People who do not smoke, who are unwilling to engage in cessation efforts, or who have medical conditions or treatments that make study measurements unevaluable are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational program for people who currently smoke and present with a suspicious round lung lesion; they are urgently advised to quit and offered connections to smoking‑cessation counseling and pharmacotherapy if desired. Nicotine dependence is measured with the Fagerström test and biochemical markers (COHb from blood gas and urine cotinine) are taken at baseline, at the planned result discussion after inpatient histological confirmation (bronchoscopy or CT‑guided puncture), and again at 3 months. The team also records age, gender, height, weight, medications, comorbidities, and body plethysmography data. Participation does not change the clinical course or treatment decisions for the diagnostic workup.
Why it matters
Potential benefit: If successful, more patients with suspicious lung nodules may quit smoking, lowering their future risk of tobacco‑related illness and improving overall health outcomes.
How similar studies have gone: Smoking-cessation counseling with biochemical verification has helped smokers quit in other clinical settings, although applying it specifically around bronchoscopy or CT‑guided biopsy timing is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient is an active smoker by the time of the initial presentation in our pneumological outpatient clinic for the clarification of a suspicious nodule Exclusion Criteria: * Current or past medically relevant illness or treatment that could affect the evaluability of the study. * Expected lack of willingness to actively participate in study-related measures.
Where it's running
-
University RWTH Aachen
Aachen, North Rhine-Westphalia, Germany Recruiting
Study contacts
- Study coordinator: Maria Aetou Dr.med
- Email: maetou@ukaachen.de
- Phone: 00492418088763
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Intraoperative 3D Longitude-Latitude-Depth Localization vs CT-Guided Lung Localization for Small Peripheral Nodules
This study tests whether intraoperative 3D longitude–latitude–depth localization can identify 0.8–2 cm peripheral lung nodules as reliably as the standard preoperative CT-guided localization in adults undergoing VATS surgery.
-
Omega-3s and low-dose aspirin for smokers with stage III periodontitis
In adults who smoke and have stage III periodontitis, this study tests whether adding omega-3 fatty acids and a small amount of aspirin to standard cleaning helps improve gum health.
-
Tirzepatide for Smoking Cessation in people who smoke and are overweight or obese
This study tests whether tirzepatide can help adults who smoke quit and manage weight better than placebo when combined with usual smoking-cessation support.
-
mHealth program for smokers who are unsure about quitting
This study will test two smartphone stop-smoking apps—one standard version and one with extra content for people not ready to quit—to see which better helps adults who are ambivalent about quitting smoking.
-
Abuse potential of five modern oral nicotine products
This will test how five modern oral nicotine products compare with cigarettes and nicotine gum in how satisfying they feel and how much nicotine adult smokers absorb.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.